Market Place
Sourcing Support
Gilead Beats Whistleblower Lawsuit over Hepatitis C drugs
15 Sep 2025 //
REUTERS
Gilead Launches New Primary Biliary Cholangitis Campaign
10 Sep 2025 //
FIERCE PHARMA
Gilead Sciences Partners with Veeva Vault CRM
10 Sep 2025 //
PRESS RELEASE
Vyome Holdings Bolsters Team for Pivotal Trial Studies
09 Sep 2025 //
PHARMAWEB
Xilio Starts Ph 2 XTX301 Trial, Hits $17.5M Gilead Milestone
09 Sep 2025 //
GLOBENEWSWIRE
IDEAYA Reveals Ph 1/2 Trial Data of IDE397 & Trodelvy in Cancer
08 Sep 2025 //
PR NEWSWIRE
US Plans to Bring Gilead HIV Drug to Market
05 Sep 2025 //
REUTERS
Gilead Urges HIV Patients to `Choose U` in Campaign
04 Sep 2025 //
FIERCE PHARMA
Gilead Starts Construction on Development & Manufacturing Center
04 Sep 2025 //
CONTRACTPHARMA
Gilead Partners PEPFAR for Biannual Lenacapavir Supply
04 Sep 2025 //
BUSINESSWIRE
Gilead breaks ground on production hub as part of $32B US outlay
04 Sep 2025 //
FIERCE PHARMA
EU approves Gilead`s new injection for preventing HIV
27 Aug 2025 //
REUTERS
CVS Denies Coverage for Gilead`s Biannual PrEP Drug Yeztugo
21 Aug 2025 //
FIERCE PHARMA
Gilead Sciences to Attend Future Investor Conferences
20 Aug 2025 //
BUSINESSWIRE
Gilead Reports 7% Sales Decline for CAR-T`s Yescarta, Tecartus
12 Aug 2025 //
FIERCE PHARMA
Gilead Sciences`s Hepcludex Receives Approval in Canada
08 Aug 2025 //
FDA
Gilead Ends Last MASH Program, Drops 2 Cancer Assets
08 Aug 2025 //
FIERCE BIOTECH
Gilead`s CAR-Ts Yescarta, Tecartus Sales Drop by 7%
08 Aug 2025 //
FIERCE PHARMA
Gilead Confident in PrEP Despite Task Force Uncertainty
08 Aug 2025 //
BIOSPACE
Gilead Sciences Reveals Q2 2025 Financial Results
07 Aug 2025 //
BUSINESSWIRE
AbbVie, Gilead, GSK Support Annual Hepatitis Elimination Drive
29 Jul 2025 //
FIERCE PHARMA
Lilly`s Kisunla, Gilead`s Pr Ep Drug Yeytuo Gain CHMP Nods
25 Jul 2025 //
FIERCE PHARMA
Gilead Gets CHMP Nod for Lenacapavir HIV Prevention
25 Jul 2025 //
BUSINESSWIRE
EU Backs Gilead`s Twice-Yearly Injection for HIV Prevention
25 Jul 2025 //
REUTERS
Gilead Sciences to Release Second Quarter 2025 Financial Results
24 Jul 2025 //
BUSINESSWIRE
Gilead`s Ongoing Commitment to End HIV Epidemic
23 Jul 2025 //
ACCESSWIRE
Hookipa, Having Sold Off Vaccines to Gilead, Opts to Wind Down
21 Jul 2025 //
FIERCE BIOTECH
WHO recommends Gilead`s twice-yearly injection for HIV prevention
15 Jul 2025 //
REUTERS
Gilead Unveils Lenacapavir Data for HIV Prevention at IAS 2025
14 Jul 2025 //
BUSINESSWIRE
Gilead Enlists Global Fund in Access Campaign for New PrEp Med
10 Jul 2025 //
PRESS RELEASE
Gilead, Global Fund Finalize Deal for Lenacapavir HIV Prevention
09 Jul 2025 //
BUSINESSWIRE
Scotus Ruling Paves Smooth Launch Path for Gilead`s Yeztugo
02 Jul 2025 //
FIERCE PHARMA
Gilead Blames Low Infection Rates for Ending 2 RSV Trials
28 Jun 2025 //
FIERCE BIOTECH
Gilead Shares Rise After Top Court Ruling on Preventive Coverage
28 Jun 2025 //
REUTERS
Gilead Signs up to $750 Million Cancer Drug Deal with Kymera
27 Jun 2025 //
PRESS RELEASE
Gilead Shares Kim’s Story of Growing Up With HIV in 1980s
24 Jun 2025 //
ACCESSWIRE
FDA approves Gilead`s twice-yearly injection for HIV prevention
19 Jun 2025 //
PRESS RELEASE
Gilead, Arcellx Continue to Safety of Multiple Myeloma Therapy
16 Jun 2025 //
ENDPTS
FDA Pause Gilead Trials Testing Experimental HIV pill Combo
11 Jun 2025 //
REUTERS
Kite Shows Yescarta Data for Outpatient Lymphoma Care at ASCO
01 Jun 2025 //
BUSINESSWIRE
Gilead bolsters Trodelvy with first-line breast cancer win
30 May 2025 //
FIERCE PHARMA
ASCENT-03 Trodelvy Shows Benefit in 1L mTNBC Patients
23 May 2025 //
BUSINESSWIRE
Gilead`s Trodelvy Chalks up Another Phase 3 Breast Cancer Win
23 May 2025 //
FIERCE PHARMA
Gilead pays partner Hookipa $10M for HBV, HIV vaccines
23 May 2025 //
FIERCE BIOTECH
Tomas Cihlar of Gilead Sciences on TIME`s 100
20 May 2025 //
ACCESSWIRE
Gilead Sciences Ireland signs MoU for public health in Abu Dhabi
16 May 2025 //
BIOSPECTRUM
Gilead and Kite to Present Data at 2025 ASCO and EHA
15 May 2025 //
BUSINESSWIRE
Gilead Sciences: Focusing on PBC Through Patient Stories
15 May 2025 //
ACCESSWIRE
Gilead tees up $11B in new US manufacturing, R&D investments
09 May 2025 //
FIERCE PHARMA
Earth Day Focus for Gilead Sciences - Every Action Has an Impact
08 May 2025 //
ACCESSWIRE
Gilead’s Livdelzi Shows Consistent Efficacy in PBC at EASL
07 May 2025 //
BUSINESSWIRE
Bulevirtide Study Shows Sustained Viral Suppression
07 May 2025 //
BUSINESSWIRE
The Centrifuge Sessions Focus on Fighting Devastating Diseases
06 May 2025 //
ACCESSWIRE
Gilead to pay $202 M in US settlement over HIV drug kickbacks
30 Apr 2025 //
REUTERS
Gilead to Present Latest Advancements in Liver Diseases
29 Apr 2025 //
BUSINESSWIRE
Gilead Sciences to Present at Upcoming Investor Conferences
29 Apr 2025 //
BUSINESSWIRE
Gilead supports long-acting PrEP launch despite uncertainties
25 Apr 2025 //
FIERCE PHARMA
Gilead posts profit, HIV prevention drug on track for mid-June
24 Apr 2025 //
REUTERS
Gilead Sciences Announces First Quarter 2025 Financial Results
24 Apr 2025 //
BUSINESSWIRE
Gilead mounts campaign to close UK’s ‘HIV gender gap’
23 Apr 2025 //
FIERCE PHARMA
